AA
LVAC

Ancora Advisors’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Ancora Advisors’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,409
Closed -$34K – 2212
2022
Q3 		$34K Hold
3,409
– – ﹤0.01% 1197
2022
Q2 		$34K Hold
3,409
– – ﹤0.01% 1293
2022
Q1 		$34K Buy
+3,409
New +$33.8K ﹤0.01% 1405

Other funds holding LVAC

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Ancora Advisors's LVAC Position: Q4 2022 in Review

Ancora Advisors sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q4 2022, closing a stake of 3,409 shares — an estimated $34K sold.

Ancora Advisors first reported a position in LVAC in Q1 2022 and held it in 3 quarters. The position peaked at $34K in Q3 2022. 53 funds tracked by Wall St. Rank hold LVAC as of Q4 2022.

  • Ancora Advisors reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ancora Advisors sold 3,409 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $34K.
  • Ancora Advisors first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Ancora Advisors's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $34K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.